- Conditions
- Asthma
- Interventions
- QBX258, Placebo
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 15
- States / cities
- Anaheim, California • Riverside, California • Rolling Hills Estates, California + 11 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 75
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Asthma, Obesity
- Interventions
- Pioglitazone, Placebo
- Drug
- Lead sponsor
- University of Vermont
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Colchester, Vermont
- Conditions
- Asthma
- Interventions
- Omalizumab
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 20 Years to 75 Years
- Enrollment
- 133 participants
- Timeline
- 2003 – 2006
- U.S. locations
- 0
- States / cities
- Not listed
- Conditions
- Status Asthmaticus
- Interventions
- Metered Dose Inhaler & Optichamber Advantage Valve Holding Chamber (VHC), Airlife Sidestream High Efficiency Nebulizer
- Device
- Lead sponsor
- Akron Children's Hospital
- Other
- Eligibility
- 12 Months to 18 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Akron, Ohio
- Conditions
- Asthma
- Interventions
- SKP FlutiForm HFA pMDI
- Drug
- Lead sponsor
- SkyePharma AG
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 10
- States / cities
- Scottsdale, Arizona • Orange County, California • Colorado Springs, Colorado + 7 more
- Conditions
- Asthma
- Interventions
- Electronic sensor and OW education
- Behavioral
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 5 Years and older
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Asthma
- Interventions
- Combivent CFC MDI, Albuterol HFA MDI, Respimat Combivent
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 226 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2008
- U.S. locations
- 41
- States / cities
- Birmingham, Alabama • Los Angeles, California • Palmdale, California + 36 more
- Conditions
- Moderate to Severe Asthma
- Interventions
- Tezepelumab, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 12 Years to 21 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 15
- States / cities
- Bakersfield, California • Huntington Beach, California • Miami, Florida + 12 more
- Conditions
- Asthma
- Interventions
- Indacaterol 300 μg, Salmeterol 50 μg, Placebo to indacaterol, Placebo to salmeterol
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 805 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 56
- States / cities
- Glendale, Arizona • Phoenix, Arizona • Encinitas, California + 44 more
- Conditions
- Asthma
- Interventions
- Lunsekimig, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 685 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 48
- States / cities
- Scottsdale, Arizona • Yuma, Arizona • Lancaster, California + 41 more
- Conditions
- Eosinophilic Asthma
- Interventions
- KT-621, Placebo
- Drug · Other
- Lead sponsor
- Kymera Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 264 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 20
- States / cities
- Long Beach, California • Northridge, California • Redding, California + 16 more
- Conditions
- Moderate to Severe Allergic Asthma
- Interventions
- CYT003, Placebo
- Biological
- Lead sponsor
- Cytos Biotechnology AG
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 365 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 21
- States / cities
- Los Angeles, Huntington Beach, San Jose, California • Walnut Creek, San Diego, Riverside, Fountain Valley, California • Colorado Springs, Denver, Colorado + 18 more
- Conditions
- Asthma
- Interventions
- Amlitelimab, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 437 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 21
- States / cities
- La Jolla, California • Los Angeles, California • San Jose, California + 18 more
- Conditions
- Asthma
- Interventions
- Magnesium Sulfate, Placebo
- Drug
- Lead sponsor
- University of Louisville
- Other
- Eligibility
- 2 Years to 20 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
- Conditions
- Allergic Asthma
- Interventions
- Not listed
- Lead sponsor
- Joseph D. Diaz, MD
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Asthma
- Interventions
- PF-07275315, Placebo
- Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 252 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 36
- States / cities
- Mobile, Alabama • Chandler, Arizona • Lancaster, California + 29 more
- Conditions
- Asthma in Children
- Interventions
- Bi-level Positive Airway Pressure, Sham Bi-level Positive Airway Pressure
- Device
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 5 Years to 17 Years
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Asthma
- Interventions
- Dupilumab, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 10
- States / cities
- Westminster, California • Kansas City, Kansas • Ann Arbor, Michigan + 6 more
- Conditions
- Moderate-to-Severe Asthma
- Interventions
- Anti-GM-CSF Monoclonal Antibody 400mg, Placebo
- Biological · Other
- Lead sponsor
- Humanigen, Inc.
- Industry
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 33
- States / cities
- Birmingham, Alabama • Fullerton, California • Granada Hills, California + 27 more
- Conditions
- Asthma
- Interventions
- Nebulized magnesium sulfate
- Drug
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 7 Years to 18 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Asthma
- Interventions
- Dupilumab SAR231893 (REGN668)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 393 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 35
- States / cities
- Gilbert, Arizona • Scottsdale, Arizona • Tucson, Arizona + 30 more
- Conditions
- Asthma
- Interventions
- Placebo twice daily, Olodaterol low daily dose twice daily, Olodaterol medium daily dose twice daily, Olodaterol high daily dose once daily and placebo, Olodaterol medium daily dose once daily and placebo
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 206 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2011
- U.S. locations
- 12
- States / cities
- Huntington Beach, California • Centennial, Colorado • Wheat Ridge, Colorado + 9 more
- Conditions
- Moderate to Severe Asthma
- Interventions
- 3% Hypertonic Saline, 7% Hypertonic Saline, Salbutamol
- Device · Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2024
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Asthma
- Interventions
- CJM112, Placebo to CJM112
- Drug · Other
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 118 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 8
- States / cities
- Fullerton, California • Riverside, California • Denver, Colorado + 5 more